Teva Pharmaceuticals USA, Inc.

United States of America

Back to Profile

1-100 of 779 for Teva Pharmaceuticals USA, Inc. Sort by
Query
Aggregations
IP Type
        Patent 562
        Trademark 217
Jurisdiction
        World 552
        United States 142
        Europe 46
        Canada 39
Date
2025 October 4
2025 6
2024 14
2023 82
2022 100
See more
IPC Class
A61P 35/00 - Antineoplastic agents 77
A61K 9/20 - Pills, lozenges or tablets 39
C07D 471/04 - Ortho-condensed systems 29
C07D 487/04 - Ortho-condensed systems 26
A61P 25/00 - Drugs for disorders of the nervous system 23
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 212
10 - Medical apparatus and instruments 8
35 - Advertising and business services 4
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 4
36 - Financial, insurance and real estate services 3
See more
Status
Pending 133
Registered / In Force 646
  1     2     3     ...     8        Next Page

1.

TEVA TOTAL SUPPORT

      
Serial Number 99451265
Status Pending
Filing Date 2025-10-20
Owner Teva Pharmaceuticals USA, Inc. ()
NICE Classes  ?
  • 35 - Advertising and business services
  • 36 - Financial, insurance and real estate services
  • 38 - Telecommunications services
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Vendor management services for healthcare facilities; Business administration services in the field of healthcare; Filling orders for prescription pharmaceuticals Providing information and education in the field of medical benefits, including UM criteria Electronic data interchange services in the field of healthcare transactions such as claims, eligibility, claim status, electronic remittance advice, prior authorizations, attachments and referrals that allow direct transaction and payment communications between healthcare providers, specialty pharmacies and payers Providing information relating to diseases related to CNS, oncology, immunology and respiratory and pharmaceutical products used to treat those diseases, as well as information to help support initiation, ongoing compliance and adherence to therapy, and to enhance patients' knowledge of their diseases Application service provider, namely, hosting, managing, developing, analyzing, and maintaining applications, software, and web sites, of others in the fields of healthcare, benefits programs, employee productivity, risk management Healthcare services, namely, integrated healthcare services with a network of international healthcare providers

2.

TOTAL SUPPORT

      
Serial Number 99451267
Status Pending
Filing Date 2025-10-20
Owner Teva Pharmaceuticals USA, Inc. ()
NICE Classes  ?
  • 35 - Advertising and business services
  • 36 - Financial, insurance and real estate services
  • 38 - Telecommunications services
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Vendor management services for healthcare facilities; Business administration services in the field of healthcare; Filling orders for prescription pharmaceuticals Providing information and education in the field of medical benefits, including UM criteria Electronic data interchange services in the field of healthcare transactions such as claims, eligibility, claim status, electronic remittance advice, prior authorizations, attachments and referrals that allow direct transaction and payment communications between healthcare providers, specialty pharmacies and payers Providing information relating to diseases related to CNS, oncology, immunology and respiratory and pharmaceutical products used to treat those diseases, as well as information to help support initiation, ongoing compliance and adherence to therapy, and to enhance patients' knowledge of their diseases Application service provider, namely, hosting, managing, developing, analyzing, and maintaining applications, software, and web sites, of others in the fields of healthcare, benefits programs, employee productivity, risk management Healthcare services, namely, integrated healthcare services with a network of international healthcare providers

3.

TEVA TOTAL SUPPORT

      
Serial Number 99441732
Status Pending
Filing Date 2025-10-14
Owner Teva Pharmaceuticals USA, Inc. ()
NICE Classes  ?
  • 35 - Advertising and business services
  • 38 - Telecommunications services
  • 36 - Financial, insurance and real estate services
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Vendor management services for healthcare facilities; Business administration services in the field of healthcare; Filling orders for prescription pharmaceuticals Electronic data interchange services in the field of healthcare transactions such as claims, eligibility, claim status, electronic remittance advice, prior authorizations, attachments and referrals that allow direct transaction and payment communications between healthcare providers, specialty pharmacies and payers Providing information and education in the field of medical benefits, including UM criteria Providing information relating to diseases related to CNS, oncology, immunology and respiratory and pharmaceutical products used to treat those diseases, as well as information to help support initiation, ongoing compliance and adherence to therapy, and to enhance patients' knowledge of their diseases Application service provider, namely, hosting, managing, developing, analyzing, and maintaining applications, software, and web sites, of others in the fields of healthcare, benefits programs, employee productivity, risk management Healthcare services, namely, integrated healthcare services with a network of international healthcare providers

4.

SIMLANDI

      
Serial Number 99425494
Status Pending
Filing Date 2025-10-02
Owner Teva Pharmaceuticals USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment of autoimmune diseases

5.

TRUOZA

      
Serial Number 99105594
Status Pending
Filing Date 2025-03-26
Owner TEVA PHARMACEUTICALS USA, INC. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment and prevention of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders

6.

MIZKO

      
Serial Number 99080422
Status Pending
Filing Date 2025-03-12
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations, namely, injectable contraceptives; Oral contraceptives; Hormones for medical purposes

7.

GOMOSDI

      
Application Number 019098808
Status Registered
Filing Date 2024-10-30
Registration Date 2025-03-19
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

8.

IMOSIPA

      
Application Number 019098810
Status Registered
Filing Date 2024-10-30
Registration Date 2025-03-19
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

9.

GOSEMDO

      
Application Number 019098824
Status Registered
Filing Date 2024-10-30
Registration Date 2025-03-19
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

10.

GOSEMDO FUSA

      
Serial Number 98817992
Status Pending
Filing Date 2024-10-24
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases

11.

IMOSIPA FUSA

      
Serial Number 98817999
Status Pending
Filing Date 2024-10-24
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases

12.

GOMOSDI FUSA

      
Serial Number 98818002
Status Pending
Filing Date 2024-10-24
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases

13.

GOSEMDO VICI

      
Serial Number 98818004
Status Pending
Filing Date 2024-10-24
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases by prescription only

14.

GOMOSDI VICI

      
Serial Number 98818012
Status Pending
Filing Date 2024-10-24
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases by prescription only

15.

IMOSIPA VICI

      
Serial Number 98818008
Status Pending
Filing Date 2024-10-24
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases by prescription only

16.

ZINFAMEL

      
Serial Number 98802332
Status Pending
Filing Date 2024-10-15
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment of neurological diseases, respiratory diseases, cancer and pain; oral contraceptives and contraceptive preparations

17.

GOSEMDI

      
Application Number 232058200
Status Pending
Filing Date 2024-04-10
Owner Teva Pharmaceuticals USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, and urological diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, menopause, ophthalmological disorders and diseases, and pain; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of endocrine diseases and disorders, namely, growth and thyroid disorders; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of psychological disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders, and psychoses.

18.

GOSEMDI

      
Application Number 019011806
Status Registered
Filing Date 2024-04-10
Registration Date 2024-09-03
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of inflammatory and autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

19.

RIVELSA

      
Serial Number 98446014
Status Registered
Filing Date 2024-03-12
Registration Date 2024-12-17
Owner Teva Pharmaceuticals USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations, namely, oral contraceptives.

20.

PRE-FILLED SYRINGE

      
Application Number 18382136
Status Pending
Filing Date 2023-10-20
First Publication Date 2024-02-08
Owner Teva Pharmaceuticals USA, Inc. (USA)
Inventor
  • Joguparthi, Vijay
  • Lobrutto, Rosario

Abstract

An auto-injector device includes a pre-filled syringe including a container and a stainless steel needle adhered to the container with at least one of a urethane acrylate adhesive or a urethane methacrylate adhesive. The container is filled with at least 1 mL of a pharmaceutical composition comprising epinephrine, a buffer, and water, where the pharmaceutical composition has a pH ranging between 3 and 4. The auto-injector device also includes a firing mechanism that expels about 0.3 mL of the pharmaceutical composition from the container in less than 0.5 seconds during a single injection.

IPC Classes  ?

  • A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
  • C09J 175/16 - Polyurethanes having carbon-to-carbon unsaturated bonds having terminal carbon-to-carbon unsaturated bonds
  • A61K 47/02 - Inorganic compounds
  • A61L 31/02 - Inorganic materials
  • A61L 31/04 - Macromolecular materials
  • A61L 31/16 - Biologically active materials, e.g. therapeutic substances
  • A61M 5/20 - Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
  • A61M 5/31 - Syringes Details
  • A61M 5/315 - PistonsPiston-rodsGuiding, blocking or restricting the movement of the rodAppliances on the rod for facilitating dosing
  • A61M 5/32 - NeedlesDetails of needles pertaining to their connection with syringe or hubAccessories for bringing the needle into, or holding the needle on, the bodyDevices for protection of needles
  • A61M 5/34 - Constructions for connecting the needle

21.

PROCESSES FOR THE PREPARATION OF FINERENONE

      
Application Number US2023018968
Publication Number 2023/205164
Status In Force
Filing Date 2023-04-18
Publication Date 2023-10-26
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Rengasamy, Vadivelan
  • Ariyamuthu, Sundaraselvan
  • Mandewale, Mustapha
  • Subbireddy, Elluru
  • Kapoor, Gaurav
  • Mukherjee, Soumya
  • Nighot, Dnyaneshwar
  • Kushwaha, Sandeep Kumar

Abstract

The present disclosure encompasses processes for the preparation of (S)-Finerenone.

IPC Classes  ?

  • C07D 401/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring- member bond

22.

SOLID STATE FORMS OF LX9211 AND SALTS THEREOF

      
Application Number US2023015992
Publication Number 2023/183443
Status In Force
Filing Date 2023-03-23
Publication Date 2023-09-28
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Škalec Šamec, Dijana
  • Karadakić, Klara
  • Barbaro, Tea
  • Landeka, Ivana

Abstract

The present disclosure encompasses solid state forms of LX9211, salts and cocrystals thereof, in embodiments processes for preparation thereof, and pharmaceutical compositions thereof.

IPC Classes  ?

  • C07D 213/65 - One oxygen atom attached in position 3 or 5
  • A61P 25/28 - Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
  • A61K 31/444 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. amrinone

23.

SOLID STATE FORMS OF TOLEBRUTINIB AND OF TOLEBRUTINIB SALTS

      
Application Number US2023014868
Publication Number 2023/172663
Status In Force
Filing Date 2023-03-09
Publication Date 2023-09-14
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor Kordić, Lorena

Abstract

The present disclosure encompasses solid state forms of Tolebrutinib and of Tolebrutinib salts, in embodiments crystalline polymorphs of Tolebrutinib and of Tolebrutinib salts, processes for preparation thereof, and pharmaceutical compositions thereof. In particular, the present invention discloses crystalline polymorphs, salts and co-crystals of Tolebrutinib.

IPC Classes  ?

  • C07D 471/04 - Ortho-condensed systems
  • A61P 35/00 - Antineoplastic agents
  • A61K 31/437 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline

24.

SOLID STATE FORMS OF SELTOREXANT

      
Application Number US2023013572
Publication Number 2023/163964
Status In Force
Filing Date 2023-02-22
Publication Date 2023-08-31
Owner
  • TEVA CZECH INDUSTRIES S.R.O. (Czech Republic)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Kolesa, Pavel
  • Przeczková, Zuzana
  • Bártová, Adéla
  • Romanová, Jana

Abstract

Solid state forms of Seltorexant HCl and processes for preparation thereof, and pharmaceutical compositions thereof are disclosed.

IPC Classes  ?

  • C07D 487/12 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups in which the condensed system contains three hetero rings
  • A61P 25/24 - Antidepressants

25.

CRYSTALLINE FORMS OF TRILACICLIB AND TRILACICLIB SALTS

      
Application Number US2023014031
Publication Number 2023/164255
Status In Force
Filing Date 2023-02-28
Publication Date 2023-08-31
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Muthusamy, Anantha Rajmohan
  • Putikum, Rahul Kumar Reddy
  • Rengaraj, Prathap
  • Singh, Amit
  • Kadu, Rushikesh Vilasrao
  • Singh, Satnam

Abstract

The present disclosure encompasses solid state forms of Trilaciclib and Trilaciclib citrate salt, in embodiments polymorphs of Trilaciclib and Trilaciclib citrate salt, processes for preparation thereof, pharmaceutical compositions and uses thereof.

IPC Classes  ?

  • A61P 35/00 - Antineoplastic agents
  • C07D 487/20 - Spiro-condensed systems
  • A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings

26.

SOLID STATE FORMS OF GUSACITINIB

      
Application Number US2023013668
Publication Number 2023/164024
Status In Force
Filing Date 2023-02-23
Publication Date 2023-08-31
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Muthusamy, Anantha Rajmohan
  • Singh, Amit
  • Singh, Chanchal
  • Rengaraj, Prathap

Abstract

The present disclosure encompasses solid state forms of Gusacitinib, in embodiments crystalline polymorphs of Gusacitinib, processes for preparation thereof, and pharmaceutical compositions thereof.

IPC Classes  ?

  • C07D 487/04 - Ortho-condensed systems
  • A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
  • A61P 3/00 - Drugs for disorders of the metabolism
  • A61P 11/00 - Drugs for disorders of the respiratory system
  • A61P 17/00 - Drugs for dermatological disorders

27.

SOLID STATE FORMS OF DANICOPAN AND PROCESS THEREOF

      
Application Number US2023013270
Publication Number 2023/158772
Status In Force
Filing Date 2023-02-17
Publication Date 2023-08-24
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Muthusamy, Anantha Rajmohan
  • Somasundaram, Meenakshi Sundaram

Abstract

The present disclosure relates to Danicopan solid state forms, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.

IPC Classes  ?

  • C07D 403/14 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
  • A61K 31/506 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
  • A61P 7/00 - Drugs for disorders of the blood or the extracellular fluid

28.

PROCESSES FOR PREPARATION OF AVACOPAN AND INTERMEDIATES THEREOF

      
Application Number US2023013189
Publication Number 2023/158722
Status In Force
Filing Date 2023-02-16
Publication Date 2023-08-24
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Gyűjtő, Imre
  • Paál, Tihamér
  • Juhász, Zsuzsa Pótáriné
  • Eszenyi, Dániel
  • Zahuczky, Gábor József
  • Kondor, Zoltán
  • Rengasamy, Vadivelan
  • Prajapaty, Ramkaran
  • Daund, Vaibhav Suresh
  • Sainger, Shachi
  • Kadu, Rushikesh
  • Sharma, Vishal

Abstract

The present disclosure encompasses a process for chiral resolution of racemic amines, particularly ethyl 2-(4-((tert-butoxycarbonyl)amino)phenyl)piperidine-3-carboxylate, into its desired isomer, ethyl (2R,3S)-2-(4-((tert-butoxycarbonyl)amino)phenyl)-piperidine-3-carboxylate, which is an intermediate useful in the synthesis of Avacopan.

IPC Classes  ?

  • C12P 13/00 - Preparation of nitrogen-containing organic compounds
  • C12P 17/12 - Nitrogen as only ring hetero atom containing a six-membered hetero ring
  • C12N 9/06 - Oxidoreductases (1.), e.g. luciferase acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
  • C07D 221/00 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

29.

CONNECTD

      
Serial Number 98135426
Status Registered
Filing Date 2023-08-16
Registration Date 2024-12-24
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Medical services, namely, providing information relating to tardive dyskinesia to medical and health care professionals

30.

COVLA

      
Serial Number 98130997
Status Pending
Filing Date 2023-08-14
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

31.

SOLID STATE FORMS OF TIPIFARNIB AND PROCESS FOR PREPARATION THEREOF

      
Application Number US2023010894
Publication Number 2023/141082
Status In Force
Filing Date 2023-01-17
Publication Date 2023-07-27
Owner
  • TEVA CZECH INDUSTRIES S.R.O. (Czech Republic)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Muthusamy, Anantha Rajmohan
  • Singh, Amit
  • Rengaraj, Prathap

Abstract

The present disclosure encompasses solid state forms of Tipifarnib, processes for preparation thereof, and pharmaceutical compositions thereof.

IPC Classes  ?

  • C07D 401/06 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
  • A61P 35/00 - Antineoplastic agents
  • A61K 31/4704 - 2-Quinolinones, e.g. carbostyril
  • A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings

32.

SOLID STATE FORMS OF RUCAPARIB TOSYLATE

      
Application Number US2023010592
Publication Number 2023/137060
Status In Force
Filing Date 2023-01-11
Publication Date 2023-07-20
Owner
  • ASSIA CHEMICAL INDUSTRIES LTD. (Israel)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Škalec Šamec, Dijana
  • Travančić, Valentina
  • Šahnić, Damir

Abstract

The present disclosure encompasses solid state forms of Rucaparib Tosylate, and pharmaceutical compositions thereof.

IPC Classes  ?

  • A61P 35/00 - Antineoplastic agents
  • A61K 31/55 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
  • C07D 487/04 - Ortho-condensed systems

33.

IMPROVED PROCESSES FOR THE PREPARATION OF RIPRETINIB

      
Application Number US2022053916
Publication Number 2023/122322
Status In Force
Filing Date 2022-12-23
Publication Date 2023-06-29
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Luthra, Parven Kumar
  • Sinha, Chandrasekhar
  • Arote, Nitin Dnyaneshwar
  • Pandey, Anand Kumar
  • Tyagi, Bhupendra Prakash
  • Sonar, Jitendra Kamalakar
  • Jaiswal, Sanjay
  • Mistry, Maulik Dipakbhai

Abstract

The present invention relates to safe and improved processes for the preparation of substantially pure intermediates of formula Va and their use in the synthesis of Ripretinib and salts thereof.

IPC Classes  ?

34.

SHARED SOLUTIONS PHARMACY

      
Serial Number 98057115
Status Pending
Filing Date 2023-06-23
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 35 - Advertising and business services

Goods & Services

Filling orders for prescription pharmaceuticals

35.

SOLID STATE FORMS OF LOTILANER AND PROCESS FOR PREPARATION THEREOF

      
Application Number US2022052335
Publication Number 2023/107660
Status In Force
Filing Date 2022-12-09
Publication Date 2023-06-15
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Muthusamy, Anantha Rajmohan
  • Singh, Amit

Abstract

The present disclosure encompasses a solid-state form of Lotilaner, in embodiment processes for preparation thereof, and pharmaceutical compositions thereof. The present disclosure further encompasses Lotilaner salts and their solid state forms, as well as processes for preparation thereof, and pharmaceutical compositions thereof.

IPC Classes  ?

  • C07D 413/04 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring- member bond
  • A61K 31/422 - Oxazoles not condensed and containing further heterocyclic rings
  • A61P 27/00 - Drugs for disorders of the senses
  • A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

36.

FIDALTO

      
Serial Number 98041823
Status Pending
Filing Date 2023-06-14
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

37.

NEOLESK

      
Serial Number 98041827
Status Pending
Filing Date 2023-06-14
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

38.

LONGAVO

      
Serial Number 98041822
Status Pending
Filing Date 2023-06-14
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

39.

ZELVRI

      
Serial Number 98041833
Status Pending
Filing Date 2023-06-14
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

40.

TIZAYA

      
Serial Number 98041838
Status Pending
Filing Date 2023-06-14
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

41.

QVOSO

      
Application Number 226316900
Status Registered
Filing Date 2023-06-09
Registration Date 2025-09-08
Owner Teva Pharmaceuticals USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders, and psychoses; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations for human use; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of circulatory system diseases and disorders; Pharmaceutical preparations for the treatment of sensory organ disorders; Pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for the treatment of peripheral nervous system disorders; Pharmaceutical preparations for the treatment of neurological disorders, namely, Huntington's disease, cerebral palsy, myasthenia gravia, brain injury, spinal cord injury, seizure disorders.

42.

SOLID STATE FORMS OF DEUCRAVACITINIB, DEUCRAVACITINIB HCL AND PROCESS FOR PREPARATION OF DEUCRAVACITINIB AND INTERMEDIATES

      
Application Number US2022051466
Publication Number 2023/102085
Status In Force
Filing Date 2022-12-01
Publication Date 2023-06-08
Owner
  • TEVA CZECH INDUSTRIES S.R.O. (Czech Republic)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Šagud, Ivana
  • Biljan, Tomislav
  • Samardzic, Zrinka Mastelic
  • Dancevic Momcilovic, Tina
  • Ljubic, Anabela
  • Kos, Marija
  • Škalec Šamec, Dijana
  • Travančić, Valentina

Abstract

The present disclosure encompasses solid state forms of Deucravacitinib : L- tartaric acid or Deucravacitinib - L-tartrate, as well as processes for preparation of Deucravacitinib and intermediates thereof.

IPC Classes  ?

  • C07D 403/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

43.

SOLID STATE FORMS OF TAVAPADON AND PROCESSES FOR PREPARATION THEREOF

      
Application Number US2022051470
Publication Number 2023/102087
Status In Force
Filing Date 2022-12-01
Publication Date 2023-06-08
Owner
  • TEVA CZECH INDUSTRIES S.R.O (Czech Republic)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Przeczková, Zuzana
  • Bártová, Adéla
  • Kolesa, Pavel
  • Jegorov, Alexandr
  • Romanová, Jana

Abstract

The present disclosure encompasses solid state forms of Tavapadon, processes for preparation thereof, and pharmaceutical compositions thereof.

IPC Classes  ?

  • C07D 401/12 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
  • A61P 25/16 - Anti-Parkinson drugs
  • A61K 31/444 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. amrinone

44.

SOLID STATE FORMS OF NIROGACESTAT SALTS

      
Application Number US2022050833
Publication Number 2023/096954
Status In Force
Filing Date 2022-11-23
Publication Date 2023-06-01
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Muthusamy, Anantha Rajmohan
  • Singh, Amit

Abstract

The present disclosure encompasses solid state forms of Nirogacestat salts, in embodiments crystalline polymorphs of Nirogacestat salts, processes for preparation thereof, and pharmaceutical compositions thereof.

IPC Classes  ?

45.

SOLID STATE FORM OF TAFAMIDIS

      
Application Number US2022050182
Publication Number 2023/091534
Status In Force
Filing Date 2022-11-17
Publication Date 2023-05-25
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Matecic Musanic, Sanja
  • Travancic, Valentina
  • Pavlicic, Dubravka
  • Ratkaj, Marina

Abstract

The present disclosure relates to a solid state form of Tafamidis, processes for preparation thereof and pharmaceutical compositions thereof.

IPC Classes  ?

  • C07D 263/57 - Aryl or substituted aryl radicals
  • A61P 25/00 - Drugs for disorders of the nervous system
  • A61K 31/423 - Oxazoles condensed with carbocyclic rings

46.

SOLID STATE FORMS OF ENSIFENTRINE AND PROCESS FOR PREPARATION THEREOF

      
Application Number US2022047642
Publication Number 2023/076205
Status In Force
Filing Date 2022-10-25
Publication Date 2023-05-04
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Muthusamy, Anantha Rajmohan
  • Putikum, Rahul Kumar Reddy

Abstract

The present disclosure encompasses solid state forms of Ensifentrine, in embodiments crystalline polymorphs or salts of Ensifentrine, particularly Ensifentrine ethane-1,2-disulfonate, processes for preparation thereof, and pharmaceutical compositions thereof.

IPC Classes  ?

  • C07D 471/04 - Ortho-condensed systems
  • A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
  • A61P 37/08 - Antiallergic agents
  • A61P 11/06 - Antiasthmatics

47.

SOLID STATE FORMS OF ELACESTRANT AND PROCESSES FOR PREPARATION THEREOF

      
Application Number US2022046645
Publication Number 2023/064519
Status In Force
Filing Date 2022-10-14
Publication Date 2023-04-20
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Kordic, Lorena
  • Travancic, Valentina
  • Landeka, Ivana
  • Janton, Nikolina

Abstract

The present invention concerns a co-crystal of Elacestrant dihydrochloride and urea, its use in the preparation of another solid state form of Elecestrant or a salt thereof, and pharmaceutical compositions thereof.

IPC Classes  ?

  • C07C 217/84 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
  • C07C 275/02 - SaltsComplexesAddition compounds
  • A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
  • A61K 31/17 - Amides, e.g. hydroxamic acids having the group N—C(O)—N or N—C(S)—N, e.g. urea, thiourea, carmustine
  • A61P 35/00 - Antineoplastic agents

48.

TRINQUIS

      
Serial Number 97896222
Status Pending
Filing Date 2023-04-19
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications. Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

49.

DEMTEGE

      
Serial Number 97896225
Status Pending
Filing Date 2023-04-19
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications. Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

50.

ADHUMA

      
Application Number 018859176
Status Registered
Filing Date 2023-04-06
Registration Date 2023-08-19
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, neurological, pain, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology.

51.

ACCEMPA

      
Application Number 018859244
Status Registered
Filing Date 2023-04-06
Registration Date 2023-08-18
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

52.

ADHUMA

      
Application Number 224997000
Status Pending
Filing Date 2023-04-05
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, gastrointestinal, immunological, menopausal, pain, respiratory, and urological diseases and disorders; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for the treatment of endocrine diseases and disorders, namely, growth and thyroid disorders; pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, Huntington's disease, schizophrenia, cerebral palsy, myasthenia gravia, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of viral diseases and disorders, namely, pharmaceutical anti-viral agents.

53.

ABEQUO

      
Application Number 224996800
Status Pending
Filing Date 2023-04-05
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, and urological diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, menopause, ophthalmological disorders and diseases, and pain; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of endocrine diseases and disorders, namely, growth and thyroid disorders; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of psychological disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders, and psychoses.

54.

ACCEMPA

      
Serial Number 97873904
Status Pending
Filing Date 2023-04-05
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

55.

SOLID STATE FORMS OF IPATASERTIB CITRATE

      
Application Number US2022043579
Publication Number 2023/043869
Status In Force
Filing Date 2022-09-15
Publication Date 2023-03-23
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Škalec Šamec, Dijana
  • Karadakić, Klara

Abstract

The present invention encompasses salts and solid state forms of Ipatasertib and pharmaceutical compositions thereof.

IPC Classes  ?

  • C07D 239/70 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
  • A61P 35/00 - Antineoplastic agents
  • A61K 31/517 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

56.

SOLID STATE FORMS OF VERICIGUAT AND PROCESS FOR PREPARATION THEREOF

      
Application Number US2022042129
Publication Number 2023/034364
Status In Force
Filing Date 2022-08-31
Publication Date 2023-03-09
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Katsav, Luna Ben-Sahel
  • Goldshtein, Jenny
  • Adani, Limor
  • Masarwa, Abed
  • Muthusamy, Anantha Rajmohan
  • Somasundaram, Meenakshi Sundaram
  • Muppalla, Siva Rama Krishna
  • Pandey, Anand Kumar
  • Sonar, Jitendra Kamalakar
  • Kumar, Sumit

Abstract

The present disclosure encompasses solid state forms of Vericiguat, in embodiments crystalline polymorphs of Vericiguat, processes for preparation thereof, and pharmaceutical compositions thereof.

IPC Classes  ?

  • C07D 471/04 - Ortho-condensed systems
  • A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
  • A61P 9/00 - Drugs for disorders of the cardiovascular system

57.

POLYMORPHS OF PONESIMOD

      
Application Number US2022039770
Publication Number 2023/022896
Status In Force
Filing Date 2022-08-09
Publication Date 2023-02-23
Owner
  • TEVA CZECH INDUSTRIES S.R.O (Czech Republic)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Patel, Rohit Dwarkabhai
  • Borase, Vinod Ramesh
  • Muthusamy, Anantha Rajmohan
  • Singh, Amit

Abstract

The present disclosure encompasses Ponesimod crystalline forms, processes for preparation thereof, and pharmaceutical compositions thereof.

IPC Classes  ?

58.

JOURNESS

      
Serial Number 97794287
Status Pending
Filing Date 2023-02-14
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

59.

CAMRESE

      
Serial Number 97778192
Status Registered
Filing Date 2023-02-02
Registration Date 2024-02-20
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceuticals, namely, oral contraceptives, hormone replacement therapies and hormonal agents for treating disorders and conditions related to women's health

60.

BEAUTESSE

      
Serial Number 97774835
Status Pending
Filing Date 2023-01-31
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

61.

PONSYMDI

      
Serial Number 97774843
Status Pending
Filing Date 2023-01-31
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

62.

IMOSIPA

      
Serial Number 97774845
Status Pending
Filing Date 2023-01-31
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

63.

GOSEMDO

      
Serial Number 97774849
Status Pending
Filing Date 2023-01-31
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

64.

GOSEMDA

      
Serial Number 97774850
Status Pending
Filing Date 2023-01-31
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

65.

GOMOSDI

      
Serial Number 97774855
Status Pending
Filing Date 2023-01-31
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

66.

GOLMPODI

      
Serial Number 97774857
Status Pending
Filing Date 2023-01-31
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

67.

SIPLIMU

      
Serial Number 97774867
Status Pending
Filing Date 2023-01-31
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

68.

CHAKRA

      
Serial Number 97774841
Status Pending
Filing Date 2023-01-31
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations, namely, oral and injectable contraceptives; women's hormone replacement therapy preparations

69.

EMZIPODI

      
Serial Number 97774860
Status Pending
Filing Date 2023-01-31
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

70.

SMIODI

      
Serial Number 97774864
Status Pending
Filing Date 2023-01-31
Owner TEVA PHARMACEUTICALS USA, Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

71.

SOLID STATE FORMS OF AMCENESTRANT

      
Application Number US2022037052
Publication Number 2023/287938
Status In Force
Filing Date 2022-07-14
Publication Date 2023-01-19
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Kordić, Lorena
  • Matečić Mušanić, Sanja
  • Barbaro, Tea

Abstract

The present disclosure encompasses solid state forms of Amcenestrant, in embodiments crystalline polymorphs of Amcenestrant, processes for preparation thereof, and pharmaceutical compositions thereof.

IPC Classes  ?

  • C07D 207/12 - Oxygen or sulfur atoms
  • A61P 35/00 - Antineoplastic agents
  • A61K 31/40 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

72.

Ralpoi

      
Application Number 018822086
Status Registered
Filing Date 2023-01-13
Registration Date 2023-05-17
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

73.

Osjuvma

      
Application Number 018823129
Status Registered
Filing Date 2023-01-13
Registration Date 2023-05-17
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

74.

Geovma

      
Application Number 018823130
Status Registered
Filing Date 2023-01-13
Registration Date 2023-05-17
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

75.

DENPODSU

      
Application Number 018823169
Status Registered
Filing Date 2023-01-13
Registration Date 2023-05-17
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

76.

POZUDEMA

      
Application Number 018823471
Status Registered
Filing Date 2023-01-13
Registration Date 2023-05-17
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

77.

Podusma

      
Application Number 018823486
Status Registered
Filing Date 2023-01-13
Registration Date 2023-05-17
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

78.

Podenmo

      
Application Number 018822087
Status Registered
Filing Date 2023-01-13
Registration Date 2023-05-17
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

79.

PONLIMSI

      
Application Number 018822088
Status Registered
Filing Date 2023-01-13
Registration Date 2023-05-17
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

80.

Dejevma

      
Application Number 018823163
Status Registered
Filing Date 2023-01-13
Registration Date 2023-05-17
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

81.

Denjevma

      
Application Number 018823188
Status Registered
Filing Date 2023-01-13
Registration Date 2023-05-17
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

82.

Xavejma

      
Application Number 018823465
Status Registered
Filing Date 2023-01-13
Registration Date 2023-05-17
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

83.

Yejexma

      
Application Number 018823467
Status Registered
Filing Date 2023-01-13
Registration Date 2023-05-17
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

84.

Poduzma

      
Application Number 018823484
Status Registered
Filing Date 2023-01-13
Registration Date 2023-05-17
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

85.

Denpodma

      
Application Number 018823488
Status Registered
Filing Date 2023-01-13
Registration Date 2023-05-17
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin); Pharmaceutical preparations for the prevention and treatment of musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

86.

Podsuma

      
Application Number 018823489
Status Registered
Filing Date 2023-01-13
Registration Date 2023-05-17
Owner TEVA PHARMACEUTICALS USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Pharmaceutical preparations for the treatment of bone diseases, excluding bone cancer.

87.

SOLID STATE FORMS OF 4-[[4-(4-CHLOROANILINO)FURO[2,3-D]PYRIDAZIN-7- YL]OXYMETHYL]-N-METHYLPYRIDINE-2-CARBOXAMIDE AND SALT THEREOF

      
Application Number US2022035413
Publication Number 2023/283080
Status In Force
Filing Date 2022-06-29
Publication Date 2023-01-12
Owner
  • TEVA PHARMACEUTICALS INTERNATIONAL GMBH (Switzerland)
  • TEVA PHARMACEUTICALS USA, INC. (USA)
Inventor
  • Luthra, Parven Kumar
  • Muthusamy, Anantha Rajmohan
  • Somasundaram, Meenakshi Sundaram
  • Putikum, Rahul Kumar Reddy

Abstract

The present disclosure relates to solid state forms of Telatinib and Telatinib mesylate, processes for their preparation, and pharmaceutical compositions thereof (I).

IPC Classes  ?

  • C07D 491/048 - Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered

88.

OSJUVMA

      
Application Number 223272200
Status Pending
Filing Date 2023-01-10
Owner Teva Pharmaceuticals USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, and urological diseases and disorders; pharmaceutical preparations for use in the treatment of oncological diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, menopause, ophthalmological disorders and diseases, and pain; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of endocrine diseases and disorders, namely, growth and thyroid disorders; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of psychological disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders, and psychoses.

89.

DENJEVMA

      
Application Number 223272300
Status Pending
Filing Date 2023-01-10
Owner Teva Pharmaceuticals USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

90.

GEOVMA

      
Application Number 223272500
Status Pending
Filing Date 2023-01-10
Owner Teva Pharmaceuticals USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, and urological diseases and disorders; pharmaceutical preparations for use in the treatment of oncological diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, menopause, ophthalmological disorders and diseases, and pain; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of endocrine diseases and disorders, namely, growth and thyroid disorders; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of psychological disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders, and psychoses.

91.

XAVEJMA

      
Application Number 223272600
Status Pending
Filing Date 2023-01-10
Owner Teva Pharmaceuticals USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

92.

YEJEXMA

      
Application Number 223272700
Status Pending
Filing Date 2023-01-10
Owner Teva Pharmaceuticals USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

93.

DEJEVMA

      
Application Number 223272100
Status Pending
Filing Date 2023-01-10
Owner Teva Pharmaceuticals USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

94.

PODENMO

      
Application Number 223262200
Status Pending
Filing Date 2023-01-09
Owner Teva Pharmaceuticals USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, and urological diseases and disorders; pharmaceutical preparations for use in the treatment of oncological diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, menopause, ophthalmological disorders and diseases, and pain; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of endocrine diseases and disorders, namely, growth and thyroid disorders; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of psychological disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders, and psychoses.

95.

DENPODSU

      
Application Number 223263500
Status Registered
Filing Date 2023-01-09
Registration Date 2025-11-21
Owner Teva Pharmaceuticals USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

96.

RALPOI

      
Application Number 223262400
Status Pending
Filing Date 2023-01-09
Owner Teva Pharmaceuticals USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, and urological diseases and disorders; pharmaceutical preparations for use in the treatment of oncological diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, menopause, ophthalmological disorders and diseases, and pain; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of endocrine diseases and disorders, namely, growth and thyroid disorders; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of psychological disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders, and psychoses.

97.

POZUDEMA

      
Application Number 223264200
Status Pending
Filing Date 2023-01-09
Owner Teva Pharmaceuticals USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

98.

DENPODMA

      
Application Number 223263800
Status Registered
Filing Date 2023-01-09
Registration Date 2025-11-21
Owner Teva Pharmaceuticals USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.

99.

PONLIMSI

      
Application Number 223262100
Status Pending
Filing Date 2023-01-09
Owner Teva Pharmaceuticals USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, and urological diseases and disorders; pharmaceutical preparations for use in the treatment of oncological diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, menopause, ophthalmological disorders and diseases, and pain; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of endocrine diseases and disorders, namely, growth and thyroid disorders; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for use in urology; pharmaceutical preparations for the treatment of infectious diseases, namely, respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of psychological disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders, and psychoses.

100.

PODUSMA

      
Application Number 223264000
Status Pending
Filing Date 2023-01-09
Owner Teva Pharmaceuticals USA, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations.
  1     2     3     ...     8        Next Page